Additionally, the appetite-suppressing effects may alter eating patterns, potentially leading to irregular meal timing or consumption of foods that are more difficult to digest
GLP-1 (Glucagon-Like Peptide-1) helps: Increase satiety (feeling full) Reduce appetite Improve insulin response This is the primary mechanism used in earlier weight loss injections
References Yang L, Choi SK, Shin HJ, Han HK (2013) 3-aminopropyl functionalized magnesium phyllosilicate as an organoclay based drug carrier for improving the bioavailability of flurbiprofen
Tesamorelin: FDA-approved for reducing visceral adipose tissue in HIV-associated lipodystrophy, but widely studied for its role in fat loss, metabolic improvement, and GH stimulation
These changes can support fat loss goals but warrant attention to ensure adequate nutrition
Int J Mol Sci 23(9):4539 Wen S, Cao C, Ge J, Yang W, Wang Y, Mou Y (2023) Research progress of H 2 S donors conjugate drugs based on ADTOH